Datasets

2 datasets

HealthData.Gov

Research Article: Journal of Biomedicine and Biotechnology

Tamoxifen, a potent anticancer agent known to interrupt the enhanced estrogen activity of malignant mammary gland cells, was recently approved by the Food and Drug Administration (FDA) for the treatment of breast…

HTML

Updated Oct 29, 2026

HealthData.Gov

Possible attenuation of the G2 DNA damage cell cycle checkpoint in HeLa cells by extremely low frequency (ELF) electromagnetic fields

Background The issue remains unresolved as to whether low frequency magnetic fields can affect cell behaviour, with the possibility that they may be in part responsible for the increased incidence of leukaemia in parts…

HTML

Updated Oct 29, 2026